HUMA - Humacyte - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HUMA is currently covered by 7 analysts with an average price target of $10.88. This is a potential upside of $8.65 (387.89%) from yesterday's end of day stock price of $2.23.

Humacyte's activity chart (see below) currently has 17 price targets and 62 ratings on display. The stock rating distribution of HUMA is 93.88% BUY and 6.12% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.13% with an average time for these price targets to be met of 136.25 days.

Highest price target for HUMA is $25, Lowest price target is $10, average price target is $13.

Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 09-Jun-2025. First documented stock forecast 20-Jul-2021.

Currently out of the existing stock ratings of HUMA, 46 are a BUY (93.88%), 3 are a HOLD (6.12%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$25

$22.69 (982.25%)

$25

15 days ago
(09-Jun-2025)

0/11 (0%)

$22.44 (876.56%)

Buy

$14

$11.69 (506.06%)

1 months 10 days ago
(14-May-2025)

0/13 (0%)

$12.13 (648.66%)

Buy

$15

$12.69 (549.35%)

$15

3 months 12 days ago
(12-Mar-2025)

1/6 (16.67%)

$12.01 (401.67%)

155

Buy

$10

$7.69 (332.90%)

$7.5

8 months 6 days ago
(18-Oct-2024)

2/5 (40%)

$4.97 (98.81%)

270

Buy

$10

$7.69 (332.90%)

$10

8 months 6 days ago
(18-Oct-2024)

1/6 (16.67%)

$4.97 (98.81%)

430

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HUMA (Humacyte) average time for price targets to be met?

On average it took 136.25 days on average for the stock forecasts to be realized with a an average price target met ratio 26.13

Which analyst has the current highest performing score on HUMA (Humacyte) with a proven track record?

KRISTEN KLUSKA

Which analyst has the current lower performing score on HUMA (Humacyte) with a proven track record?

VERNON BERNARDINO

Which analyst has the most public recommendations on HUMA (Humacyte)?

Kristen Kluska works at CANTOR FITZGERALD and has 2 price targets and 3 ratings on HUMA

Which analyst is the currently most bullish on HUMA (Humacyte)?

Jason Kolbert with highest potential upside - $22.69

Which analyst is the currently most reserved on HUMA (Humacyte)?

Matt O'brien with lowest potential downside - $1.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?